West Pharmaceutical Services, Inc.WSTNYSE
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank56
5Y CAGR-20.0%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-20.0%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.54% |
| Q3 2025 | 7.43% |
| Q2 2025 | 17.40% |
| Q1 2025 | -15.20% |
| Q4 2024 | 3.47% |
| Q3 2024 | 14.66% |
| Q2 2024 | 0.00% |
| Q1 2024 | -17.10% |
| Q4 2023 | -3.63% |
| Q3 2023 | -0.92% |
| Q2 2023 | 7.98% |
| Q1 2023 | 2.73% |
| Q4 2022 | -1.53% |
| Q3 2022 | -16.35% |
| Q2 2022 | 12.29% |
| Q1 2022 | -2.67% |
| Q4 2021 | 1.42% |
| Q3 2021 | -8.82% |
| Q2 2021 | 16.02% |
| Q1 2021 | 28.94% |
| Q4 2020 | 10.79% |
| Q3 2020 | -1.85% |
| Q2 2020 | 16.47% |
| Q1 2020 | 5.96% |
| Q4 2019 | 6.99% |
| Q3 2019 | -6.48% |
| Q2 2019 | 7.51% |
| Q1 2019 | 10.23% |
| Q4 2018 | -1.92% |
| Q3 2018 | -4.98% |
| Q2 2018 | 5.40% |
| Q1 2018 | 4.56% |
| Q4 2017 | 2.86% |
| Q3 2017 | 0.40% |
| Q2 2017 | -6.63% |
| Q1 2017 | 9.02% |
| Q4 2016 | 1.65% |
| Q3 2016 | -9.15% |
| Q2 2016 | 8.11% |
| Q1 2016 | 3.09% |